Immunology and Microbiology
Infection
87%
Virus
85%
Influenza Virus
79%
Influenza
57%
Human Immunodeficiency Virus
53%
Influenzavirus A
48%
Human Immunodeficiency Virus 1
47%
Hemagglutinin
36%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
interferon
33%
Viral Disease
30%
Ribonucleic Acid
27%
Influenza Vaccine
23%
COVID-19
21%
Influenza A Virus (H1N1)
19%
Replication
17%
Antibody Response
16%
Immune Response
16%
Epitope
16%
Innate Immune System
15%
T Cell
15%
Newcastle Disease Virus
14%
Viral Replication
13%
In Vitro
13%
Spike
13%
Neutralizing Antibody
13%
Infectious Agent
13%
Influenza B Virus
11%
Titer
10%
Monoclonal Antibody
9%
Neutralization
9%
Dendritic Cell
8%
Influenza A Virus (H5N1)
8%
Wild Type
8%
Human Immunodeficiency Virus Infection
8%
Glycoprotein
8%
Aves
8%
Virus Strain
8%
CD4
7%
Cytotoxic T-Cell
7%
Immunogenicity
7%
T-Helper Cell
6%
Gene Expression
6%
Influenza Virus Hemagglutinin
6%
Nucleoprotein
6%
Amino Acid
6%
Blood Plasma
6%
RIG-I
6%
B Cell
6%
Viral Protein
5%
Viral Load
5%
Antiviral Activity
5%
Susceptibility
5%
Peptides
5%
Virion
5%
Omicron Coronavirus Variant
5%
Mouse Model
5%
Humoral Immunity
5%
Hepatitis C Virus
5%
Synapse
5%
Hepatitis C
5%
RNA Virus
5%
Mustela Putorius Furo
5%
Adoptive Immunity
5%
Viral Vector
5%
Lineages
5%
Virus Transmission
5%
Influenza A Virus (H3N2)
5%
Recombinant Virus
5%
Cytokine
5%
Keyphrases
Influenza Virus
100%
Virus
65%
COVID-19
63%
AIDS/HIV
44%
Human Immunodeficiency Virus Type 1 (HIV-1)
36%
Hemagglutinin
26%
Interferon-α (IFN-α)
21%
People Living with HIV (PLHIV)
20%
Influenza
19%
Vaccination
18%
Influenza-like Illness
18%
New York City
16%
Influenza Vaccine
16%
Viral
15%
HIV Patients
15%
Antiretroviral Therapy
14%
Antibody Response
14%
Hepatitis C Virus
13%
United States
12%
Newcastle Disease Virus
12%
NS1 Protein
12%
HIV Infection
12%
NS1′
11%
Innate Immune Response
11%
Influenza B Virus
11%
Confidence Interval
10%
Neuraminidase
10%
Epitope
10%
T Cells
10%
Retinoic Acid-inducible Gene I (RIG-I)
10%
Type I Interferon
10%
Viral Infection
9%
Immune Response
9%
Influenza A
9%
Infectious Diseases
9%
Hemagglutinin Stalk
9%
Monoclonal Antibody
9%
Neutralizing Antibodies
8%
Antiviral Activity
8%
Non-structural Protein
8%
Recombinant
8%
Pregenomic RNA (pgRNA)
8%
Infected Cells
8%
HIV-1 Infection
8%
Universal Vaccine
8%
COVID-19 Pandemic
8%
Chimeric Hemagglutinin
7%
Lung
7%
H1N1
7%
Immunogenicity
7%
Viral Replication
7%
Pandemic Influenza Virus
7%
Specific Antibodies
7%
Immunization
7%
1918 Influenza Pandemic
6%
Virulence
6%
REPRIEVE
6%
Clinical Trials
6%
Dendritic Cells
6%
Influenza Virus Hemagglutinin
6%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
6%
Avian Influenza
6%
Vaccine Candidate
6%
Stalk Domain
6%
Virus Transmission
6%
Nucleoprotein
5%
Meta-analysis
5%
Reverse Genetics
5%
Risk Factors
5%
CD4 Count
5%
Antiviral Response
5%
Solid Organ Transplant Recipients
5%
Virus Infection
5%
Titer
5%
Hepatitis C Virus Infection
5%
SARS-CoV-2 Infection
5%
Mouse Model
5%
Human Immunodeficiency Virus Infection
5%
Gp120
5%
Virological Synapse
5%
Clinical Outcomes
5%
Ferret
5%
Mount Sinai
5%
Virus Replication
5%
Recombinant Virus
5%
Virion
5%
High Risk
5%
Medicine and Dentistry
Human Immunodeficiency Virus
59%
Infection
44%
COVID-19
34%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Diseases
17%
Virus
11%
Hepatitis C Virus
8%
Influenza Virus
7%
Pathogen
7%
Infectious Disease
7%
Hepatitis C
6%
Human Immunodeficiency Virus Infection
6%
Malignant Neoplasm
6%
Acquired Immune Deficiency Syndrome
6%
Antiretroviral Therapy
5%
Lung Cancer
5%
Placebo
5%
Anal Cancer
5%
Antivirus Agent
5%
Wart Virus
5%
Public Health
5%
Virus Infection
5%